Subjective and objective measures of the patient experience before, during, and after intravitreal anti–vascular endothelial growth factor injections
| Autor: | Ashish Khodifad, Suresh Mekala, Pankaja Dhoble, CR Vishwaraj, Olivia M Hess, GS Lavanya |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Vascular Endothelial Growth Factor A
Visual analogue scale Vital signs Angiogenesis Inhibitors vital signs lcsh:Ophthalmology Pain assessment Ranibizumab Patient experience Heart rate Medicine Humans Aged Anti vegf anti-vegf business.industry Pain scale Middle Aged Bevacizumab Patient Outcome Assessment visual experience Ophthalmology lcsh:RE1-994 Anesthesia Intravitreal Injections Observational study Original Article pain scale business |
| Zdroj: | Indian Journal of Ophthalmology, Vol 69, Iss 4, Pp 890-894 (2021) Indian Journal of Ophthalmology |
| ISSN: | 1998-3689 0301-4738 |
| Popis: | Purpose: To assess patient experience of intravitreal injections using vital-signs, visual-experience, pain-rating and emotional response during intravitreal anti-VEGF injections. Methods: A prospective observational study of patient experience of intravitreal anti-VEGF injections done following metrics were collected pre-injection, during injection, and post-injection: pain assessment using visual analog score, fear-response rating, visual-experience questionnaire, and vital-signs. Results: A total of one-hundred-and-seventy-four patients undergoing intravitreal anti-VEGF injections for retinal pathologies were included in the study. Mean age was 58.8 ± 10.4 years in 5 injections (SBP 159.7 ± 26.4, 143.2 ± 17.0) (P = 0.003), (P = 0.011). DBP, heart rate, pulse rate measurements were similar among patients in all phases of the study. Conclusion: We report a large sample size with comprehensive assessments of the patient experience. Higher pain ratings in the |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |